Jump to:
loading...| Preferred Name |
pertuzumab |
|
| Synonyms |
|
|
| ID |
http://purl.obolibrary.org/obo/dinto_DB06366 |
|
| AHFScode |
10:00 |
|
| ATCCode |
L01XC13 |
|
| CASRN |
380610-27-5 |
|
| DBBrand |
perjeta |
|
| DBSynonym |
r1273 monoclonal antibody 2c4 omnitarg 2c4 antibody rhumab-2c4 moab 2c4 |
|
| Definition |
Pertuzumab is a recombinant humanized monoclonal antibody that targets the extracellular dimerization domain (Subdomain II) of the human epidermal growth factor receptor 2 protein (HER2). It consists of two heavy chains and two lights chains that have 448 and 214 residues respectively. FDA approved June 8, 2012. |
|
| has pharmacological target | ||
| label |
pertuzumab |
|
| prefixIRI |
obo2:dinto_DB06366 |
|
| prefLabel |
pertuzumab |
|
| related with | ||
| xref |
Wikipedia:http://en.wikipedia.org/wiki/Pertuzumab Drugs.com:http://www.drugs.com/perjeta.html RxList:www.rxlist.com/perjeta-drug.htm National Drug Code Directory:50242-145-01 |
|
| subClassOf |
Create mapping